[PLX] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
13-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -89.40%
YoY- -10.21%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 3,707 2,686 7,383 1,122 3,359 3,064 3,968 -4.43%
PBT -8,010 -6,119 -7,345 -10,885 -5,747 -6,837 -4,321 50.84%
Tax 49 202 38 0 0 0 0 -
NP -8,010 -6,119 -7,345 -10,885 -5,747 -6,837 -4,321 50.84%
Tax Rate - - - - - - - -
Total Cost 11,717 8,805 14,728 12,007 9,106 9,901 8,289 25.92%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin -216.08 -227.81 -99.49 -970.14 -171.09 -223.14 -108.90 57.83%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -0.09 -0.07 -0.08 -1.18 -0.06 -0.07 -0.05 47.91%
EPS Diluted -0.09 -0.07 -0.08 -1.17 -0.06 -0.07 -0.05 47.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.